Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes	Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus	Active, not recruiting	Not stated	2025-06-04		NCT07003191

50 results · Page 1 of 2

Swipe the table sideways for more columns.

Organizations	Linked trials
Afﬁliated Hospital of North Sichuan Medical College	16
Beilun District People's Hospital	1
Changsha Fourth Hospital	2
China Resources Wugang General Hospital	2
Dengzhou People's Hospital	1
Dingzhou People's Hospital	1
Dongyang People's Hospital	16
Fifth Affiliated Hospital of Guangzhou Medical University	17
First Affiliated Hospital, Sun Yat-Sen University	113
First People's Hospital of Hangzhou	58
Huantai County People's Hospital	1
Hunan Provincial People's Hospital Ma Wang Dui Branch	1
Kaifeng People's Hospital	1
Lanzhou University Second Hospital	22
Li Hui Li Hospital	1
Liaoning Health Industry Group Benxi Steel General Hospital	1
Liaoning Health Industry Group Fushun Mining General Hospital	1
Mingguang People's Hospital	1
Nanning Second People's Hospital	4
Red Cross Hospital, Hangzhou, China	8
Ruyang County People's Hospital	1
Second Affiliated Hospital of Bengbu Medical College	4
Second Hospital of Shanxi Medical University	23
Shaanxi Hospital of Traditional Chinese Medicine	7
Shaoxing Central Hospital	8

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Endocrinology Department, The First Affiliated Hospital of Sun Yat-sen University	Guangzhou	China	1

Clinical trials